­

V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases

December 16th, 2019|V-Bio News|

V-Bio Ventures leads AgomAb Therapeutics’ Euros 21m Series A Financing

April 3rd, 2019|V-Bio News|

V-Bio Ventures leads Camel-IDS EUR 37m Series A financing to develop cancer targeted radiopharmaceuticals

November 15th, 2018|V-Bio News|

V-Bio Ventures participates in 22.5 million euros series B financing round of HORAMA

September 18th, 2018|V-Bio News|

V-Bio Ventures invests in UCB spinout Syndesi Therapeutics to develop novel therapeutics for cognitive disorders

February 1st, 2018|V-Bio News|

V-Bio Ventures leads EUR 7.7M financing of Aphea.Bio

June 16th, 2017|V-Bio News|

V-Bio Ventures invests in OCTIMET Oncology

January 19th, 2017|V-Bio News|

V-Bio Ventures closes first life sciences fund, raising over € 75 million

December 1st, 2016|V-Bio News|

V-Bio Ventures invests in VIB spinout Confo Therapeutics NV

February 2nd, 2016|V-Bio News|

First Closing of V-Bio Ventures Fund 1 with commitments of € 63 million

November 19th, 2015|V-Bio News|